- active not recruitingPHASE3
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
This study is testing a new medicine called obexelimab for IgG4-related disease. It wants to see if this medicine can stop flare-ups of the condition and if it's safe to use. Half the participants will get the new medicine and the other half will get a dummy medicine.
United States · Argentina · Canada - active not recruitingPHASE3
A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
This study is looking into a new treatment called inebilizumab for a condition called IgG4-Related Disease. It aims to see if this treatment can stop flare-ups of the disease and if it's safe to use.
United States · Argentina · Australia